H. Service-de-pharmacie and . Timone, , vol.264, p.13005

, Marseille Cedex 05

M. Faculté-de, Aix-Marseille Université, 27 boulevard Jean Moulin, 13385 Marseille Cedex 05

, Service d'Oncologie Médicale -Soins palliatifs, p.13385

, Marseille Cedex 05

G. Service-de-médecine-interne and . Et-thérapeutique, Hôpital Sainte Marguerite, 270 boulevard Sainte, vol.14, p.13385

, Marseille Cedex 05

. Ucog-paca and F. Ouest, Auteur correspondant : Docteur Anne-Laure COUDERC, Service de Médecine Interne, Gériatrie et Thérapeutique, Pôle GeST, vol.14

;. Hôpital-de-la-timone, . Ucog-paca, and F. Ouest, Résumé La polymédication de la personne âgée atteinte de cancer peut être à l'origine d'une iatrogénie médicamenteuse et majorer le risque d'effet indésirable et de réduction de doses des chimiothérapies reçues. Pour éviter cela, nous avons développé une collaboration médico-pharmaceutique en complément de l'évaluation gériatrique standardisée (EGS), vol.264

, Mots clés : collaboration médico-pharmaceutique, révision des thérapeutiques, polymédication, cancer, patient âgé

G. Nightingale, E. Skonecki, and M. K. Boparai, The Impact of Polypharmacy on Patient Outcomes in Older Adults With Cancer, Cancer J, vol.23, pp.211-219, 2017.

E. Reeve, M. D. Wiese, and A. A. Mangoni, Alterations in drug disposition in older adults, Expert Opin Drug Metab Toxicol, vol.11, pp.491-508, 2015.

M. A. Popa, K. J. Wallace, A. Brunello, M. Extermann, and L. Balducci, Potential drug interactions and chemotoxicity in older patients with cancer receiving chemotherapy, J Geriatr Oncol, vol.5, pp.307-321, 2014.

A. Whitman, K. Degregory, A. Morris, S. Mohile, and E. Ramsdale, Pharmacist-led medication assessment and deprescribing intervention for older adults with cancer and polypharmacy: a pilot study, Support Care Cancer, vol.26, pp.4105-4118, 2018.

P. Soubeyran, C. Bellera, J. Goyard, D. Heitz, H. Curé et al., Screening for Vulnerability in Older Cancer Patients: The ONCODAGE Prospective Multicenter Cohort Study. Williams BO, éditeur, PLoS One, vol.9, p.115060, 2014.

D. O'mahony, O. 'sullivan, D. Byrne, S. O'connor, M. N. Ryan et al., STOPP/ START criteria for potentially inappropriate prescribing in older people: version 2, Age Ageing, vol.44, pp.213-221, 2014.

B. Pourroy, C. Letellier, A. Helvig, B. Chanet, D. Crozals et al., Development of a rapid risk evaluation tool for herbs/drugs interactions in cancer patients: a multicentric experience in south of France, Eur J Cancer Care (Engl), vol.26, p.12752, 2017.

D. X. Sun, J. C. Lu, Z. Z. Fang, Y. Y. Zhang, Y. F. Cao et al., Reversible inhibition of three important human liver cytochrome p450 enzymes by tiliroside, Phytother Res, vol.24, pp.1670-1675, 2010.

Y. Kimura, H. Ito, and T. Hatano, Effects of mace and nutmeg on human cytochrome P450 3A4 and 2C9 activity, Biol Pharm Bull, vol.33, pp.1977-82, 2010.

F. Scotté, C. Hervé, P. Leroy, J. M. Tourani, R. J. Bensadoun et al., Supportive Care Organization in France: a national in-depth survey among patients and oncologists, Support Care Cancer, vol.25, pp.2111-2119, 2017.

F. Scotté, C. Hervé, S. Oudard, M. E. Bugat, R. Bugat et al., Supportive care organisation in France: An in depth study by the French speaking association for supportive care in cancer (AFSOS), Eur J Cancer, vol.49, pp.1090-1096, 2013.

F. Scotté, P. Bossi, C. E. Cudennec, T. Dielenseger, P. Gomes et al., Addressing the quality of life needs of older patients with cancer: a SIOG consensus paper and practical guide, Ann Oncol, vol.29, pp.1718-1744, 2018.

J. Le, Journal d'OncoGériatrie ®, vol.186, 2018.

, Révision des thérapeutiques en oncogériatrie par un binôme médecin-pharmacien ? Revision of oncogeriatric therapies by a physician-pharmacist duo

P. Soubeyran, C. Bellera, J. Goyard, D. Heitz, H. Cure et al., Validation of the G8 screening tool in geriatric oncology: The ONCODAGE project, J Clin Oncol. 20 mai, vol.29, issue.15_suppl, pp.9001-9001, 2011.

. Inca, Les cancers en France -L'essentiel des faits et chiffre -Edition, 2019.

G. Defossez, L. Guyader-peyrou, S. Uhry, Z. Grosclaude, P. Remontet et al., Estimations nationales de l'incidence et de la mortalité par cancer en France métropolitaine entre 1990 et 2018. Étude à partir des registres des cancers du réseau Francim, 2019.

A. Aouba, Les causes médicales de décès en France en 2004 et leur évolution, p.7

. Vieillissement,

D. Sur,

, Centre d'analyse stratégique. Vivre ensemble plus longtemps, 2010.

, Espérance de vie à divers âges en 2018 | Insee

, Haute Autorité de Santé -Prendre en charge une personne âgée polypathologique en soins primaires

. Inca, État des lieux et perspectives en oncogériatrie, 2009.

T. Pignon, F. Rafaramino, and P. Scalliet, Cancer and the elderly, Management. Decision patterns, vol.21, 2000.

A. Maladie, Améliorer la qualité du système de santé et maîtriser les dépenses : Propositions de l'Assurance Maladie pour 2019, 2018.

M. Extermann and L. Balducci, Optimizing cancer care in the elderly: progress in geriatric oncology, Cancer Control J Moffitt Cancer Cent. déc, vol.10, issue.6, pp.440-441, 2003.

G. B. Zulian, Geriatric medical oncology in the care of elderly cancer patients, Crit Rev Oncol Hematol. mars, vol.41, issue.3, pp.343-350, 2002.

V. Rollason and N. Vogt, Problèmes pratiques et éthiques des essais cliniques en gériatrie, Rev Med Suisse, 2001.

, Plan Cancer 2014-2019 : synthèse, 2014.

F. Trautinger, Mechanisms of photodamage of the skin and its functional consequences for skin ageing, Clin Exp Dermatol, vol.26, issue.7, pp.573-580, 2001.

J. T. Fülöp, I. Wórum, J. Csongor, G. Fóris, P. Varga et al., Body Composition in Elderly People, Gerontology, vol.31, issue.3, pp.150-157, 1985.

I. Walter-sack and U. Klotz, Influence of diet and nutritional status on drug metabolism, Clin Pharmacokinet. juill, vol.31, issue.1, pp.47-64, 1996.

A. Anantharaju, A. Feller, and A. Chedid, Aging Liver. Gerontology, vol.48, issue.6, pp.343-53, 2002.

D. L. Schmucker, Liver Function and Phase I Drug Metabolism in the Elderly: A Paradox, Drugs Aging, vol.18, issue.11, pp.837-51, 2001.

K. Turnheim, When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly, Exp Gerontol. août, vol.38, issue.8, pp.843-53, 2003.

J. R. Weinstein and S. Anderson, The Aging Kidney: Physiological Changes, Adv Chronic Kidney Dis. juill, vol.17, issue.4, pp.302-309, 2010.

R. Oberbauer, P. Krivanek, and K. Turnheim, Pharmacokinetics of Indomethacin in the Elderly, Clin Pharmacokinet. mai, vol.24, issue.5, pp.428-462, 1993.

D. Hewick, P. Newbury, S. Hopwood, G. Naylor, and J. Moody, Age as a factor affecting lithium therapy, Br J Clin Pharmacol. avr, vol.4, issue.2, pp.201-206, 1977.

R. P. Miller, R. K. Tadagavadi, G. Ramesh, and W. B. Reeves, Mechanisms of Cisplatin nephrotoxicity, Toxins, vol.2, issue.11, pp.2490-518, 2010.

M. Feinberg, The problems of anticholinergic adverse effects in older patients, Drugs Aging. août, vol.3, issue.4, pp.335-383, 1993.

P. Soubeyran, M. Fonck, C. Blanc-bisson, J. Blanc, J. Ceccaldi et al., Predictors of Early Death Risk in Older Patients Treated With First-Line Chemotherapy for Cancer, J Clin Oncol, vol.30, issue.15, pp.1829-1863, 2012.

H. B. Muss, Adjuvant Chemotherapy in Older and Younger Women With Lymph NodePositive Breast Cancer, JAMA. 2 mars, vol.293, issue.9, p.1073, 2005.

H. Hamilton, P. Gallagher, C. Ryan, S. Byrne, O. 'mahony et al., Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients, Arch Intern Med. 13 juin, vol.171, issue.11, pp.1013-1022, 2011.

M. Chan, F. Nicklason, and J. H. Vial, Adverse drug events as a cause of hospital admission in the elderly, Intern Med J. juin, vol.31, issue.4, pp.199-205, 2001.

N. Boyle, V. Naganathan, and R. G. Cumming, Medication and Falls: Risk and Optimization, Clin Geriatr Med. nov, vol.26, issue.4, pp.583-605, 2010.

V. Lemmens, M. Janssen-heijnen, C. Verheij, S. Houterman, R. Van-driel et al., Co-morbidity leads to altered treatment and worse survival of elderly patients with colorectal cancer, Br J Surg. mai, vol.92, issue.5, pp.615-638, 2005.

M. Sharma, K. P. Loh, G. Nightingale, S. G. Mohile, and H. M. Holmes, Polypharmacy and potentially inappropriate medication use in geriatric oncology, J Geriatr Oncol, vol.7, issue.5, pp.346-53, 2016.

M. Herr, J. Robine, J. Pinot, J. Arvieu, and J. Ankri, Polypharmacy and frailty: prevalence, relationship, and impact on mortality in a French sample of 2350 old people, Pharmacoepidemiol Drug Saf. juin, vol.24, issue.6, pp.637-683, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02006072

M. Herr, N. Sirven, H. Grondin, S. Pichetti, and C. Sermet, Frailty, polypharmacy, and potentially inappropriate medications in old people: findings in a representative sample of the French population, Eur J Clin Pharmacol. sept, vol.73, issue.9, pp.1165-72, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-01802861

G. K. Prithviraj, S. Koroukian, S. Margevicius, N. A. Berger, R. Bagai et al., Patient characteristics associated with polypharmacy and inappropriate prescribing of medications among older adults with cancer, J Geriatr Oncol. juill, vol.3, issue.3, pp.228-265, 2012.

, Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults, American Geriatrics Society, vol.67, issue.4, pp.674-94, 2019.

A. Whitman, K. Degregory, A. Morris, S. Mohile, and E. Ramsdale, Pharmacist-led medication assessment and deprescribing intervention for older adults with cancer and polypharmacy: a pilot study, Support Care Cancer. déc, vol.26, issue.12, pp.4105-4118, 2018.

G. Nightingale, E. Hajjar, L. T. Pizzi, M. Wang, E. Pigott et al., Implementing a pharmacist-led, individualized medication assessment and planning (iMAP) intervention to reduce medication related problems among older adults with cancer, J Geriatr Oncol. juill, vol.8, issue.4, pp.296-302, 2017.

M. Laroche, F. Bouthier, M. L. Charmes, and J. ,

, Rev Med Interne. juill, vol.30, issue.7, pp.592-601, 2009.

G. Nightingale, E. Skonecki, and M. K. Boparai, The Impact of Polypharmacy on Patient Outcomes in Older Adults With Cancer, Cancer J Sudbury Mass. août, vol.23, issue.4, pp.211-219, 2017.

M. A. Popa, K. J. Wallace, A. Brunello, M. Extermann, and L. Balducci, Potential drug interactions and chemotoxicity in older patients with cancer receiving chemotherapy, J Geriatr Oncol. juill, vol.5, issue.3, pp.307-321, 2014.

, Les unités de coordination et antennes d'oncogériatrie -Oncogériatrie

M. Extermann, M. Aapro, R. Bernabei, H. J. Cohen, J. Droz et al., Use of comprehensive geriatric assessment in older cancer patients, Crit Rev Oncol Hematol. sept, vol.55, issue.3, pp.241-52, 2005.

M. A. Gosney, Clinical assessment of elderly people with cancer, Lancet Oncol, vol.6, issue.10, pp.790-797, 2005.

M. B. Rodin and S. G. Mohile, A practical approach to geriatric assessment in oncology, J Clin Oncol Off J Am Soc Clin Oncol. 10 mai, vol.25, issue.14, pp.1936-1980, 2007.

M. Extermann and A. Hurria, Comprehensive geriatric assessment for older patients with cancer, J Clin Oncol Off J Am Soc Clin Oncol. 10 mai, vol.25, issue.14, pp.1824-1855, 2007.

C. N. Klabunde, A. Ambs, N. L. Keating, Y. He, W. R. Doucette et al., The Role of Primary Care Physicians in Cancer Care, J Gen Intern Med. sept, vol.24, issue.9, pp.1029-1065, 2009.

S. G. Mohile, W. Dale, M. R. Somerfield, M. A. Schonberg, C. M. Boyd et al., Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology, J Clin Oncol. août, vol.36, issue.22, pp.2326-2373, 2018.

Y. Guigoz, B. Vellas, and P. Garry, Mini Nutritional Assessment : a practical assessment tool for grading the nutritional state of elderly patients, Facts res gerontol, issue.4, pp.15-59, 1994.

M. F. Folstein, S. E. Folstein, and P. R. Mchugh, « Mini-mental state ». A practical method for grading the cognitive state of patients for the clinician, J Psychiatr Res, vol.12, issue.3, pp.189-98, 1975.

D. R. Royall, J. A. Cordes, and M. Polk, CLOX: an executive clock drawing task, J Neurol Neurosurg Psychiatry. 1 mai, vol.64, issue.5, pp.588-94, 1998.

J. A. Yesavage and J. I. Sheikh, Geriatric Depression Scale (GDS): Recent Evidence and Development of a Shorter Version, Clin Gerontol, vol.9, issue.1-2, pp.165-73, 1986.

S. Katz, A. B. Ford, R. W. Moskowitz, B. A. Jackson, and M. W. Jaffe, STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION, JAMA. 21 sept, vol.185, pp.914-923, 1963.

M. P. Lawton and E. M. Brody, Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living, The Gerontologist. 1 sept, vol.9, issue.3, pp.179-86, 1969.

D. Podsiadlo and S. Richardson, The timed « Up & Go »: a test of basic functional mobility for frail elderly persons, J Am Geriatr Soc. févr, vol.39, issue.2, pp.142-150, 1991.

M. D. Miller, C. F. Paradis, P. R. Houck, S. Mazumdar, J. A. Stack et al., Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale, Psychiatry Res. mars, vol.41, issue.3, pp.237-285, 1992.

M. E. Charlson, P. Pompei, K. L. Ales, and C. R. Mackenzie, A new method of classifying prognostic comorbidity in longitudinal studies: development and validation, J Chronic Dis, vol.40, issue.5, pp.373-83, 1987.

N. K. Aaronson, S. Ahmedzai, B. Bergman, M. Bullinger, A. Cull et al., The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-ofLife Instrument for Use in International Clinical Trials in Oncology, JNCI J Natl Cancer Inst. 3 mars, vol.85, issue.5, pp.365-76, 1993.

S. Wheelwright, A. Darlington, D. Fitzsimmons, P. Fayers, and J. I. Arraras, International validation of the EORTC QLQ-ELD14 questionnaire for assessment of health-related quality of life elderly patients with cancer, Br J Cancer. août, vol.109, issue.4, pp.852-860, 2013.

L. Balducci and M. Extermann, Management of cancer in the older person: a practical approach, The Oncologist, vol.5, issue.3, pp.224-261, 2000.

, Initiative des HIGH 5s Medication Reconciliation Rapport d'expérimentation sur la mise en oeuvre de la conciliation des traitements médicamenteux par neuf établissements de santé français, 2015.

, Mettre en oeuvre la conciliation des traitements médicamenteux en établissement de santé, HAS, 2018.

M. Condren, S. Bowling, B. Hall, M. Woslager, A. Shipman et al., Medication Reconciliation Across Care Transitions in the Pediatric Medical Home, Jt Comm J Qual Patient Saf. mars, 2019.

C. Eisenhower, Impact of Pharmacist-Conducted Medication Reconciliation at Discharge on Readmissions of Elderly Patients With COPD, Ann Pharmacother. févr, vol.48, issue.2, pp.203-211, 2014.

. Sfpc, Fiche mémo -Préconisations pour la pratique des bilans partagés de médication

J. J. Caro, M. Salas, A. Ward, and G. Goss, Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review, Cancer. 15 juin, vol.91, issue.12, pp.2214-2235, 2001.

T. Aparicio, J. Jouve, L. Teillet, D. Gargot, F. Subtil et al., Geriatric Factors Predict Chemotherapy Feasibility: Ancillary Results of FFCD 2001-02 Phase III Study in First-Line Chemotherapy for Metastatic Colorectal Cancer in Elderly Patients, J Clin Oncol. 10 avr, vol.31, issue.11, pp.1464-70, 2013.
URL : https://hal.archives-ouvertes.fr/hal-02088193

F. Scotté, P. Bossi, C. E. Cudennec, T. Dielenseger, P. Gomes et al., Addressing the quality of life needs of older patients with cancer: a SIOG consensus paper and practical guide, Ann Oncol. 1 août, vol.29, issue.8, pp.1718-1744, 2018.

. Irdes and . Santé, soins et protection sociale en, 2000.